Additionally, acetylation at specific residues modulates protein stability, as shown by GCN5-mediated acetylation of DACH1 at lysine 680, which enhances its interaction with USP7, protecting DACH1 from ubiquitin-mediated degradation and promoting aggressive CRC phenotypes [64]. The gene discussed is DACH1; the disease is colorectal carcinoma.